Analytical Data
-
Gene name
ACTRT2
- Application
-
Alternative Names
Actin related Protein hArpM2; Actin related Protein M2; Actin related Protein T2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8TDY3
-
Expression Region
1-377aa
-
AA Sequence
MFNPHALDSP AVIFDNGSGF CKAGLSGEFG PRHMVSSIVG HLKFQAPSAE ANQKKYFVGE EALYKQEALQ LHSPFERGLI TGWDDVERLW KHLFEWELGV KPSDQPLLAT EPSLNPRENR EKMAEVMFEN FGVPAFYLSD QAVLALYASA CVTGLVVDSG DAVTCTVPIF EGYSLPHAVT KLHVAGRDIT ELLMQLLLAS GHTFPCQLDK GLVDDIKKKL CYVALEPEKE LSRRPEEVLR EYKLPDGNII SLGDPLHQAP EALFVPQQLG SQSPGLSNMV SSSITKCDTD IQKILFGEIV LSGGTTLFHG LDDRLLKELE QLASKDTPIK ITAPPDRWFS TWIGASIVTS LSSFKQMWVT AADFKEFGTS VVQRRCF
-
Molecular Weight
41.7 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ACTRT2, or Actin Alpha Cardiac Muscle Tissue-Related Protein 2, is a member of the tropomyosin superfamily, which plays a crucial role in the regulation of cytoskeletal dynamics and muscle contraction. Understanding the function and regulation of ACTRT2 has garnered significant interest due to its potential implications in cardiovascular health and disease. Research shows that ACTRT2 is expressed in cardiac muscle and other tissues, where it interacts with actin filaments and stabilizes their structure. Abnormalities in ACTRT2 expression or function may contribute to various cardiac pathologies, including cardiomyopathies, heart failure, and other related disorders. Emerging studies have begun to elucidate the molecular mechanisms by which ACTRT2 influences actin dynamics and muscle function, highlighting its importance not only in basic cardiac physiology but also in potential therapeutic strategies. As such, investigating ACTRT2 at both the molecular and clinical levels could provide insights into its role in heart disease and facilitate the development of novel interventions aimed at restoring normal heart function or preventing cardiac dysfunction. Additionally, researchers are exploring the potential of ACTRT2 as a biomarker for assessing the risk of cardiac conditions, further emphasizing its relevance in cardiovascular research. Overall, the understanding of ACTRT2 continues to evolve, paving the way for advancements in the treatment and prevention of cardiac-related ailments.
